Biotechnology

Latest
New Repurposed Drug Offers Hope for Hand Osteoarthritis

New Repurposed Drug Offers Hope for Hand Osteoarthritis

Osteoarthritis (OA), the most common form of arthritis, is the use-related breakdown of cartilage in our joints. There is no cure currently available. However, new research points to innovative solutions ...

1229d
Moderna Present Positive data for mRNA Cancer Vaccine, Safety Concerns Remain: Experts

Moderna Present Positive data for mRNA Cancer Vaccine, Safety Concerns Remain: Experts

An experimental mRNA vaccine significantly reduced the risk of skin cancer recurrence and death in patients when used in combination with the immunotherapy Keytruda,  Moderna and Merck announced this month. Skin cancer ...

1262d
The Research Behind Remdesivir

The Research Behind Remdesivir

How a twice-shelved drug became the standard of care for the most widespread disease

1291d
Why Stem Cell Transplants for MS Work so Well

Why Stem Cell Transplants for MS Work so Well

Researchers have pinpointed why stem cell transplants work so well for multiple sclerosis. A better understanding of these mechanisms should help the treatment approach, currently approved in only a few ...

1302d
Strange New Organ Transplant Methods Raise Urgent Questions

Strange New Organ Transplant Methods Raise Urgent Questions

New techniques use organs from partially resuscitated people and look toward genetically modified pigs

1303d
South Korean Researchers Develop Neutralizer for New COVID-19 Strains

South Korean Researchers Develop Neutralizer for New COVID-19 Strains

The more the virus mutates, the better the effect

1305d
Is the Lab-Made ‘80 Percent Lethality’ COVID Real?

Is the Lab-Made ‘80 Percent Lethality’ COVID Real?

Recently, the news about Boston University creating a new type of virus became a red-hot topic. It is said that the virus has a lethality rate of 80 percent. Is ...

1310d
Supplies Still Limited More Than a Year After Monoclonal Antibodies Authorized for Treating COVID-19

Supplies Still Limited More Than a Year After Monoclonal Antibodies Authorized for Treating COVID-19

Despite being the only authorized outpatient medical therapy for preventing the worsening of COVID-19 symptoms in high-risk patients, there remains no steady supply of monoclonal antibodies from the federal government ...

1613d
Results for COVID-19 Convalescent Plasma Still Inconclusive More Than a Year After Emergency Authorization Issued

Results for COVID-19 Convalescent Plasma Still Inconclusive More Than a Year After Emergency Authorization Issued

News Analysis Data on the effectiveness of convalescent plasma for hospitalized COVID-19 patients is still inconclusive despite more than a year since the federal authority first issued an emergency use ...

1717d
NIH to Fund Study of Repurposed Drugs to Treat COVID-19 Patients at Home

NIH to Fund Study of Repurposed Drugs to Treat COVID-19 Patients at Home

The National Institutes of Health (NIH) recently announced it will fund a large randomized clinical trial to assess whether existing drugs already approved by the Food and Drug Administration (FDA) ...

1872d